Face masks, respiratory patients and COVID-19

Field	Value	Language
dc.contributor.author	Soriano, J.B.	en
dc.contributor.author	Anzueto, A.	en
dc.contributor.author	Anticevich, S.B.	en
dc.contributor.author	Kaplan, A.	en
dc.contributor.author	Miravitlles, M.	en
dc.contributor.author	Usmani, O.	en
dc.contributor.author	Papadopoulos, N.G.	en
dc.contributor.author	Puggioni, F.	en
dc.contributor.author	Walter Canonica G.	en
dc.contributor.author	Roche, N.	en
dc.contributor.author	Respiratory Effectiveness Group	en
dc.date.accessioned	2020-12-21
dc.date.available	2020-12-21
dc.date.issued	2020	en
dc.identifier.uri	https://hdl.handle.net/2123/24175
dc.language.iso	en	en
dc.rights	Other
dc.subject	COVID-19	en
dc.subject	Coronavirus	en
dc.title	Face masks, respiratory patients and COVID-19	en
dc.type	Article, Letter	en
dc.identifier.doi	10.1183/13993003.03325-2020
dc.relation.other	CSL Behring	en
dc.relation.other	AstraZeneca	en
dc.relation.other	Teva Pharmaceutical Industries	en
dc.relation.other	Sanofi España	en
dc.relation.other	Boehringer Ingelheim	en
dc.relation.other	GlaxoSmithKline, GSK	en
dc.relation.other	Chiesi Farmaceutici	en
usyd.faculty	Faculty of Medicine and Health, Sydney Medical School	en

Associated file/s

There are no files associated with this item.